| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/10/2013 | CN101626766B Improvements in and relating to medicinal compositions |
| 07/10/2013 | CN101591324B Three crystal forms of 5-methyl-7-methoxy-isoflavone, preparation method thereof, medicine composition thereof and application |
| 07/10/2013 | CN101591323B Five crystal forms of 7-hydroxy-isoflavone, preparation method thereof, medicine composition thereof and application |
| 07/10/2013 | CN101516334B Stabilizing compositions for antibiotics and methods of use |
| 07/10/2013 | CN101495480B Constrained compounds as cgrp-receptor antagonists |
| 07/10/2013 | CN101489568B Condensation products, method for their production and use thereof in medicaments, as disinfectants or as a tannin |
| 07/10/2013 | CN101463014B Diaryl benzo pyridine derivative, and its pharmaceutical composition and use thereof |
| 07/10/2013 | CN101448497B Application of composition including nitazoxanide, tizoxanide or its mixture in preparing medicine for hepatitis C |
| 07/10/2013 | CN101410362B Lipid derivatives |
| 07/10/2013 | CN101400261B Treatment of inflammatory disorders with triazole compounds |
| 07/10/2013 | CN101378742B Use of kCNQ-openers in preparing medicine for treating or reducing the symptoms of schizophrenia |
| 07/10/2013 | CN101375846B Ellagic acid supermolecule composition and preparation method |
| 07/10/2013 | CN101367794B Preparation method for quinazoline derivants and medical uses thereof |
| 07/10/2013 | CN101346396B G protein coupling acceptor antagonist for preventing and treating alzheimer's disease and use thereof |
| 07/10/2013 | CN101282957B New pharmaceutical compounds |
| 07/10/2013 | CN101253166B Sulfonamide compound |
| 07/10/2013 | CN101217954B Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 07/10/2013 | CN101130526B Aryl carbonyl derivatives as therapeutic agents |
| 07/10/2013 | CN101123953B Method for transformation of conventional and commercially important polymers into durable and rechargeable antimicrobial polymeric materials |
| 07/10/2013 | CN101087591B Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it |
| 07/09/2013 | USRE44354 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 07/09/2013 | US8481801 Fluid wound dressing comprising partially cured polyurethane |
| 07/09/2013 | US8481760 Inhibition and treatment of prostate cancer metastasis |
| 07/09/2013 | US8481750 Derivatives of 6,7-dihydro-5H-imidazo[1,2-α]imidazole-3-carboxylic acid amides |
| 07/09/2013 | US8481743 Phenylpropionamide compounds and the use thereof |
| 07/09/2013 | US8481742 Fused aromatic PTP-1B inhibitors |
| 07/09/2013 | US8481737 Solid forms of a chemokine receptor antagonist and methods of use thereof |
| 07/09/2013 | US8481733 Substituted imidazopyr- and imidazotri-azines |
| 07/09/2013 | US8481731 Compounds, pharmaceutical composition and methods relating thereto |
| 07/09/2013 | US8481730 Method of synthesis of Bosentan, its polymorphic forms and its salts |
| 07/09/2013 | US8481721 Compositions and methods for increasing telomerase activity |
| 07/09/2013 | US8481718 Method of manufacturing gel using polysaccharides as raw materials |
| 07/09/2013 | US8481716 Process for preparing an alpha-lipoic acid/cyclodextrin complex and product prepared |
| 07/09/2013 | US8481715 Methods for isolating crystalline form I of 5-azacytidine |
| 07/09/2013 | US8481696 Glycosylated glycopeptide antibiotic derivatives |
| 07/09/2013 | US8481695 Self-gelling alginate systems and uses thereof |
| 07/09/2013 | US8481600 Formulation of aspirin that is stable and showing minimal hydrolysis for parenteral administration for the treatment of cardiovascular and other disease states |
| 07/09/2013 | US8481599 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 07/09/2013 | US8481598 Stable dosage forms of levomilnacipran |
| 07/09/2013 | US8481597 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 07/09/2013 | US8481596 Polymomorph of desvenlafaxine benzoate |
| 07/09/2013 | US8481595 Compounds for the treatment of metabolic disorders |
| 07/09/2013 | US8481594 Compositions comprising jasmonic acid derivatives and use of these derivatives |
| 07/09/2013 | US8481593 Para-coumaric acid or para-hydroxycinnamic acid derivatives and their use in cosmetic or dermatological compositions |
| 07/09/2013 | US8481592 Uses of sesquiterpene derivatives |
| 07/09/2013 | US8481591 Polymeric topical compositions |
| 07/09/2013 | US8481589 Taxoid-based compositions |
| 07/09/2013 | US8481588 Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan |
| 07/09/2013 | US8481587 Substituted 2-(5-hydroxy-2-methyl-1H-indole-3-yl)acetic acids and ethers thereof and the use of same to treat viral diseases |
| 07/09/2013 | US8481586 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors |
| 07/09/2013 | US8481585 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 07/09/2013 | US8481584 1H-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors |
| 07/09/2013 | US8481583 Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea |
| 07/09/2013 | US8481582 1,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylase |
| 07/09/2013 | US8481581 S-triazolyl α-mercaptoacetanilides as inhibitors of HIV reverse transcriptase |
| 07/09/2013 | US8481580 interleukin 1, 12, tumor necrosis factor alpha, and trigger interferon- gamma antagonist; antiinflammatory , antidiabetic agent, autoimmune disorders; active side chain moiety (5-R-hydroxyhexyl) of lisofyllin, greater potency and oral bioavailability than lisofylline |
| 07/09/2013 | US8481579 Triazolyl phenyl benzenesulfonamides |
| 07/09/2013 | US8481578 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 07/09/2013 | US8481577 Amide thiazole derivative, preparation method and uses thereof |
| 07/09/2013 | US8481576 Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors |
| 07/09/2013 | US8481575 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 07/09/2013 | US8481574 Compounds as cannabinoid receptor ligands |
| 07/09/2013 | US8481573 Modulators of sphingosine phosphate receptors |
| 07/09/2013 | US8481572 Pharmaceutical compositions and methods for the treatment of cancer |
| 07/09/2013 | US8481571 Anti-coronavirus compounds |
| 07/09/2013 | US8481570 1-methylnicotinaide derivatives and formulations of treatment of lipoprotein abnormalities |
| 07/09/2013 | US8481569 Iminopyridine derivatives and use thereof |
| 07/09/2013 | US8481568 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 07/09/2013 | US8481567 Sigma receptor compounds |
| 07/09/2013 | US8481566 Compounds which have activity at M1 receptor and their uses in medicine |
| 07/09/2013 | US8481564 Inhibitors of c-fms kinase |
| 07/09/2013 | US8481563 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists |
| 07/09/2013 | US8481562 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 07/09/2013 | US8481561 Classes of GABAA/BZR ligands |
| 07/09/2013 | US8481560 Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists |
| 07/09/2013 | US8481559 Morphine and morphine precursors |
| 07/09/2013 | US8481558 Compounds to inhibit or augment an inflammatory response |
| 07/09/2013 | US8481557 Method of treatment using checkpoint kinase 1 inhibitors |
| 07/09/2013 | US8481556 Piperidinone carboxamide azaindane CGRP receptor antagonists |
| 07/09/2013 | US8481555 Aza-bicyclic amine N-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs |
| 07/09/2013 | US8481554 Solid oral dosage forms of lamivudine |
| 07/09/2013 | US8481553 Antimetastatic compounds |
| 07/09/2013 | US8481550 Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| 07/09/2013 | US8481549 Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents |
| 07/09/2013 | US8481548 2-[4-(2-chloro-pyridin-4-ylethynyl)-2-methyl-imidazol-1-yl]-4-trifluoromethyl-pyrimidine; metabotropic glutamate (mGluR5) receptor antagonist; analgesic, neurodegenerative diseases; psychosis, epilepsy, schizophrenia, Alzheimer' disease, cognititve disorders, memory deficits, chronic and acute pain |
| 07/09/2013 | US8481547 Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of DPP-1 |
| 07/09/2013 | US8481546 CGRP receptor antagonist |
| 07/09/2013 | US8481545 3-(imidazolyl)-pyrazolo[3,4-b] pyridines |
| 07/09/2013 | US8481544 Antibacterial compositions |
| 07/09/2013 | US8481543 Compounds for treating parasitic disease |
| 07/09/2013 | US8481542 Pyridazinyl derivatives as smo inhibitors |
| 07/09/2013 | US8481541 Pyrrolopyrazine kinase inhibitors |
| 07/09/2013 | US8481540 Inhibitors of bruton's tyrosine kinase |
| 07/09/2013 | US8481539 Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 07/09/2013 | US8481538 Heterocyclic inhibitors of c-Met and uses thereof |
| 07/09/2013 | US8481537 Caspase inhibitors based of pyridazinone scaffold |
| 07/09/2013 | US8481536 Benzotriazine inhibitors of kinases |
| 07/09/2013 | US8481535 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor |
| 07/09/2013 | US8481534 5- and 6-membered heterocyclic compounds |
| 07/09/2013 | US8481533 Kinase inhibitors and method of treating cancer |